- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed DLBCL and PT/NKCLs in Japan
Total 878 results
-
Otsuka Pharmaceutical Co., Ltd.H. Lundbeck A/SCompleted
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruiting
-
Otsuka Pharmaceutical Co., Ltd.H. Lundbeck A/SCompleted
-
Otsuka Pharmaceutical Co., Ltd.H. Lundbeck A/SCompleted
-
SymBio PharmaceuticalsCompletedAssess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCLJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Kyushu UniversityRecruitingPediatric Solid Tumors | Refractory/Relapse NeuroblastomaJapan
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDiabetes MellitusJapan
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan
-
Novo Nordisk A/SCompletedHealthy Volunteers Type 2 DiabetesJapan
-
Novartis PharmaceuticalsCompletedMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaItaly, Australia, Germany, Spain, France, Japan, United States
-
Kochi UniversityRecruiting
-
Kochi UniversityRecruitingPancreatic AdenocarcinomaJapan
-
Hiroshima UniversitySBI Pharmaceuticals Co, Ltd.Completed
-
OncoTherapy Science, Inc.TerminatedRelapsed or Refractory Synovial SarcomaJapan
-
NovartisCompletedSubfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)Japan
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLS With Exon 20 Insertion MutationUnited States, Spain, Canada, Italy, Israel, Japan, United Kingdom, Korea, Republic of, Germany, France, Turkey, Belgium, Netherlands, Philippines, Poland, Singapore
-
Osaka Saiseikai Nakatsu HospitalCompletedDiabetes MellitusJapan
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruiting
-
Kyowa Kirin Co., Ltd.CompletedHyperparathyroidismJapan
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Ito HospitalCompletedThyroid Disease | Parathyroid DiseaseJapan
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Hiroshima UniversityKAWAMOTO FOODS CO., LTD.Completed
-
Tadashi HasegawaCompleted
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
Novo Nordisk A/SCompletedFoetal Growth Problem | Small for Gestational AgeJapan
-
National Cerebral and Cardiovascular CenterRecruitingDiabetes Mellitus, Type 2Japan
-
Jikei University School of MedicineNovo Nordisk A/SUnknown
-
Kochi UniversityUnknown
-
Osaka City UniversityCompleted
-
Hiroshima UniversityNewBio Enterprise Co., ltd.Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
TakedaCompletedDiabetes Mellitus, Type 2Japan
-
Nihon Pharmaceutical Co., LtdCompletedStevens-Johnson Syndrome | Toxic Epidermal NecrolysisJapan
-
Kansai Electric Power HospitalSaiseikai Noe Hospital OsakaCompletedDiabetes Mellitus, Type 2Japan
-
Translational Research Center for Medical Innovation...Astellas Pharma Inc; Osaka Saiseikai Nakatsu HospitalCompletedDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan